Remedy Entertainment Oyj (HEL:REMEDY)

Paramount Global Statistics

Total Valuation

HEL:REMEDY has a market cap or net worth of EUR 217.43 million. The enterprise value is 224.95 million.

Market Cap	217.43M
Enterprise Value	224.95M

Important Dates

The last earnings date was Tuesday, August 12, 2025.

Earnings Date	Aug 12, 2025
Ex-Dividend Date	n/a

Share Statistics

HEL:REMEDY has 13.64 million shares outstanding. The number of shares has increased by 1.34% in one year.

Current Share Class	13.64M
Shares Outstanding	13.64M
Shares Change (YoY)	+1.34%
Shares Change (QoQ)	+4.09%
Owned by Insiders (%)	44.96%
Owned by Institutions (%)	8.30%
Float	5.50M

Valuation Ratios

The trailing PE ratio is 340.26 and the forward PE ratio is 39.68.

PE Ratio	340.26
Forward PE	39.68
PS Ratio	3.63
PB Ratio	3.13
P/TBV Ratio	7.86
P/FCF Ratio	n/a
P/OCF Ratio	47.17
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 18.18, with an EV/FCF ratio of -102.44.

EV / Earnings	352.04
EV / Sales	3.76
EV / EBITDA	18.18
EV / EBIT	122.06
EV / FCF	-102.44

Financial Position

The company has a current ratio of 3.93, with a Debt / Equity ratio of 0.25.

Current Ratio	3.93
Quick Ratio	2.32
Debt / Equity	0.25
Debt / EBITDA	1.42
Debt / FCF	-7.99
Interest Coverage	1.44

Financial Efficiency

Return on equity (ROE) is 0.95% and return on invested capital (ROIC) is 1.47%.

Return on Equity (ROE)	0.95%
Return on Assets (ROA)	1.23%
Return on Invested Capital (ROIC)	1.47%
Return on Capital Employed (ROCE)	2.13%
Revenue Per Employee	160,402
Profits Per Employee	1,713
Employee Count	367
Asset Turnover	0.64
Inventory Turnover	n/a

Taxes

In the past 12 months, HEL:REMEDY has paid 988,000 in taxes.

Income Tax	988,000
Effective Tax Rate	60.73%

Stock Price Statistics

The stock price has decreased by -11.11% in the last 52 weeks. The beta is 0.77, so HEL:REMEDY's price volatility has been lower than the market average.

Beta (5Y)	0.77
52-Week Price Change	-11.11%
50-Day Moving Average	15.75
200-Day Moving Average	14.85
Relative Strength Index (RSI)	46.55
Average Volume (20 Days)	8,237

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HEL:REMEDY had revenue of EUR 59.83 million and earned 639,000 in profits. Earnings per share was 0.05.

Revenue	59.83M
Gross Profit	45.68M
Operating Income	1.84M
Pretax Income	1.63M
Net Income	639,000
EBITDA	10.99M
EBIT	1.84M
Earnings Per Share (EPS)	0.05

Balance Sheet

The company has 10.03 million in cash and 17.55 million in debt, giving a net cash position of -7.52 million or -0.55 per share.

Cash & Cash Equivalents	10.03M
Total Debt	17.55M
Net Cash	-7.52M
Net Cash Per Share	-0.55
Equity (Book Value)	69.57M
Book Value Per Share	4.90
Working Capital	31.91M

Cash Flow

In the last 12 months, operating cash flow was 4.61 million and capital expenditures -6.81 million, giving a free cash flow of -2.20 million.

Operating Cash Flow	4.61M
Capital Expenditures	-6.81M
Free Cash Flow	-2.20M
FCF Per Share	-0.16

Margins

Gross margin is 76.36%, with operating and profit margins of 3.08% and 1.07%.

Gross Margin	76.36%
Operating Margin	3.08%
Pretax Margin	2.72%
Profit Margin	1.07%
EBITDA Margin	18.37%
EBIT Margin	3.08%
FCF Margin	n/a

Dividends & Yields

HEL:REMEDY does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.34%
Shareholder Yield	n/a
Earnings Yield	0.29%
FCF Yield	-1.01%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	7